Randolph Corteling, our Chief Scientific Officer, presented at the event on Tuesday 14 March. His presentation entitled – ‘CustomEXTM a new stem cell-derived drug delivery platform’, highlighted the advantages of ReNeuron’s customisable stem-cell derived exosome drug delivery platform (CustomEXTM) over current technologies.

The presentation can be viewed by clicking here.

Back